September, 2022

article thumbnail

How environmental factors could influence disease and drugs

Pharmaceutical Technology

The study of lifetime exposures, also known as the “exposome”, is providing a new perspective on how environmental and social factors affect disease pathways and general wellbeing, and could influence the way pharma researches drugs.

article thumbnail

In surprise result, Alzheimer’s drug from Eisai, Biogen shows benefit in large trial

Bio Pharma Dive

The companies said the drug, called lecanemab, met all of its goals in the Phase 3 study. The data are a significant finding and provide stronger support for a much-debated hypothesis for treating Alzheimer’s

Trials 285
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Historic Day in Drug Development: FDA Approves Amylyx’s Drug to Treat ALS, Demonstrating FDA’s Application of Appropriate Flexibility in Rare Diseases

The FDA Law Blog

By Frank J. Sasinowski & James E. Valentine — On September 29, 2022, FDA approved Amylyx’s NDA for its drug, Relyvrio (sodium phenylbutyrate/taurursodiol), for treatment of patients with amyotrophic lateral sclerosis (ALS) (see FDA announcement here ).

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

Wall Street wants growth, as do investors, but that may be impossible for pharmaceutical companies. In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs.

Marketing 183
article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

Almirall:Tildrakizumab is the first and only IL-23p19 inhibitor to demonstrate meaningful sleep improvement in people living with psoriasis

Pharma Mirror

Barcelon, a global biopharmaceutical company focused on skin health, announced at the 31st EADV (European Association of Dermatology and Venereology) Congress the results from TRIBUTE, an interventional phase IV clinical study, which resembled real-life clinical practice. In this study, Ilumetri®?

article thumbnail

Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19

The Pharma Data

More Trending

article thumbnail

ALS drug approved by FDA in closely watched decision, marking win for patients, developer

Bio Pharma Dive

The drug, which will be sold as Relyvrio, showed modest benefits in function and survival in testing. It also became the latest test of the FDA's flexibility toward new therapies for neurological disorders

article thumbnail

Genetically modified herpes combats advanced cancers

Pharma Times

A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial

article thumbnail

Is Apple that naive when it comes to compliance?

World of DTC Marketing

Apple’s Health app gets new capabilities with iOS 16. The Health app adds Medications, allowing users to conveniently build and manage a medications list, create schedules and reminders, and track their medications, vitamins, or supplements. Will it matter?

article thumbnail

Syntegon Group appoints Dr. Peter Hackel as Chief Financial Officer

Pharma Mirror

Waiblingen/Germany, The Syntegon Group, a globally leadingsupplier of processing and packaging technology, intends to appoint Dr. Peter Hackelas member of the Executive Board at the beginning of 2023.

Packaging 130
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

FDA Approves Spesolimab-Sbzo Injection for GPP Flares in adults

The Pharma Data

article thumbnail

Micro-robots, smart toilets, and 3D bioprinted organs: the future of healthcare

Pharmaceutical Technology

It is the year 2030. You have just received the results from your whole genome sequencing test, offered through your public health provider, and discovered that you have a 75% chance of developing a rare form of cancer.

Genome 271
article thumbnail

Sarepta asks FDA to approve first gene therapy for Duchenne muscular dystrophy

Bio Pharma Dive

The application comes a year earlier than previously had been expected, as company says drug reviewers are open to accelerated review based on data from early-stage trials

article thumbnail

Peli BioThermal Introduces Tokyo Service Center

Pharmaceutical Commerce

New facility will focus on company’s temperature-controlled pallet shipper rental program.

83
article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

EVERSANA INTOUCH Wins Agency of the Year

Intouch Solutions

Faruk Capan Named Advertising Agency CEO of the Year in PM360 Trailblazer Awards. KANSAS CITY – Sept.

article thumbnail

Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022

Pharma Mirror

REHOVOT, Israel & WILMINGTON Ayala Pharmaceuticals, Inc.

article thumbnail

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The Pharma Data

The first large, real- world study of the effectiveness of mRNA COVID- 19 vaccines during gestation set up these vaccines, especially two original boluses followed by a supporter, are effective in guarding against serious complaint in expectant maters whether the shots are administered before or during gestation.

article thumbnail

Tetra and Cellvera partner to develop oral Covid-19 treatment

Pharmaceutical Technology

Tetra Bio-Pharma and Cellvera have entered an agreement to jointly develop ARDS-003 as an oral combination therapeutic candidate with 400mg Qifenda (Favipiravir) for Covid-19. A first-in-human drug product, ARDS-003 contains the active pharmaceutical agent, Onternabez.

RNA 264
article thumbnail

Bluebird wins FDA approval of gene therapy for rare brain disorder

Bio Pharma Dive

The therapy, called Skysona and cleared to treat cerebral adrenoleukodystrophy, is the product of more than a decade of work by Bluebird. It will cost $3 million

article thumbnail

Increasing trial participation for new cancer treatments

Elsevier

Thanks to new and innovative treatments, cancer survival rates continue to improve dramatically – and this will likely only accelerate in the future.

article thumbnail

Keyword Coverage: Comparing Top SEO Tools

Intouch Solutions

When you’re looking at keywords, how do you know if you’re seeing everything that’s out there? Sadly, you probably aren’t. No tool is perfect. But which one is best?

article thumbnail

Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines

Pharma Mirror

Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.

Branding 130
article thumbnail

Dupixent ®( dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis

The Pharma Data

Dupixent ®( dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis Dupixent significantly reduced itch and skin lesions compared to placebo in direct- to- Phase 3 program conforming of two vital trials About,000 grown-ups in theU.S.

article thumbnail

AstraZeneca on the hunt for new acquisitions

Pharmaceutical Technology

Following AstraZeneca’s success in vaccine development during the Covid-19 pandemic , the pharmaceutical giant is now looking to expand its scope through acquisitions across a range of indications, says CEO Pascal Soriot. “We We want to be a sustainably growing company.

article thumbnail

Sangamo presses ahead with Fabry disease gene therapy

Bio Pharma Dive

Preliminary results from a Phase 1 study show Sangamo’s treatment to be safe and suggest it is working as intended, leading the biotech to move into the trial’s next phase

article thumbnail

Succeeding as an Insecure Overachiever

Pharmaceutical Commerce

Professor Laura Empson pulls back the curtain on insecure overachieving professionals and explains how they can come to accept damaging patterns of overwork as inevitable and even desirable.

83
article thumbnail

Tilt collaborates with MSD on immunotherapy clinical trial

Pharma Times

The study will focus on checkpoint inhibitor refractory non-small cell lung cancer

article thumbnail

STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer

Pharma Mirror

Cambridge, UK: STORM Therapeutics Ltd.

RNA 130
article thumbnail

Breakthrough brings potential glioblastoma drug into focus

The Pharma Data

Glioblastoma, the most common cancerous brain excrescence in grown-ups, is an aggressive complaint- cases survive an normal of just 15 months once they’re diagnosed.

Protein 82
article thumbnail

bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies

Pharmaceutical Technology

After several setbacks, bluebird bio bounces back with two major FDA gene therapy approvals. Last month, Zynteglo (betibeglogene autotemcel), or beti-cel, was approved as a one-time potentially curative gene therapy for patients with beta-thalassaemia who require regular blood transfusions.

article thumbnail

FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases

Bio Pharma Dive

The public-private partnership plans to bring together scientific experts, private entities and patient groups to better understand certain neurodegenerative disorders and find new treatments

article thumbnail

Arcturus announces $63m award from US government to support development of self-amplifying mRNA vaccine

BioPharma Reporter

Arcturus Therapeutics has obtained an award for up to $63.2m

article thumbnail

HeartBeat.bio and Molecular Devices link up to automate cardiac organoids

Pharma Times

Collaboration will involve sophisticated screening for cardiac-based drug discovery

Drugs 116
article thumbnail

The discovery of a new and compounding cybersecurity threat to pharmacies

Pharma Phorum

Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised.

Pharmacy 109